Product Description: 
Cartalax is a tripeptide bioregulator developed from cartilage tissue, belonging to the same family of peptide bioregulators pioneered by Russian researchers at the St. Petersburg Institute of Bioregulation and Gerontology. Bioregulator peptides are short-chain amino acid sequences believed to interact directly with DNA to normalize cellular function in specific tissue types. Current research has explored Cartalax in the following contexts: cartilage tissue regeneration and repair mechanisms, joint health and connective tissue biology, age-related cartilage degradation models, and bioregulator peptide interactions with chondrocyte function.
 
Specifications: 20mg | Lyophilized powder | Purity ≥98% | Store at 2–8°C
 
For Research Use Only. Not intended for human or veterinary use.
 
Structure
Chemical composition and molecular properties
Amino Acid Sequence: Ala-Glu-Asp (AED)
Molecular Formula: C12H19N3O8
Molecular Weight: 333.29 g/mol
PubChem CID: 87815447
Synonyms: T-31, AED, SCHEMBL5324601, Alanyl-glutamyl-aspartic acid
 
PRODUCT USAGE
THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.